介入および一般心臓学ジャーナル

Progress in Treatment of Atrial Fibrillation

Abstract

Lili Jin1 and Ruiqin Xie2*

Atrial fibrillation (AF) is the most common supraventricular arrhythmia in clinical practice. Rapid, unordered atrial electroactivity is the characteristic of AF. The main manifestations of the electrocardiogram are P wave disappeared and RR interval irregular absolutely (except for the three degree atrioventricular block). Atrial irregular contractions cause atrial thrombosis. The irregular contraction of ventricle leading to a decrease in cardiac pump function, which can seriously affect ventricular systolic and diastolic function. In 2010, about 33.5 million people suffered from AF around the world. In the European Union, there are an estimated 14 million to 17 million people with AF by 2030. In the United States, there are about 27 million to 61 million AF patients. With the trend of population aging in recent years, the incidence of AF increases gradually. AF is not only a great challenge for cardiologists, but also a hot research topic. The following review is in the treatment progress of AF in recent years.